We plan in generations. This is reflected in our more than 100 years of successful company history. It is also at the core of sustainability. The importance of sustainability and of the interconnection between human, animal and environmental health – commonly referred to as One Health – is firmly anchored in our philosophy. We take our responsibility in this area very seriously and are actively integrating sustainability considerations into our business strategy.
Our Ambition is to Improve Animal Health Today and in the Future
Monitor
We will leverage new technologies and science in order to monitor in real time and detect disease earlier
Diagnose
We will develop novel tools that support targeted therapy in livestock
Prevent
Together we can provide tailored and comprehensive programs to safeguard animal health today and in the future
As a global leader in the animal health industry our more than 9,500 employees serve more than 150 markets worldwide. We are one of the largest providers of vaccines, parasiticides and therapeutics, complemented by diagnostics and monitoring platforms. With a strong presence in the companion animal and livestock segments, we support veterinarians, farmers as well as pet and horse owners. As part of family-owned Boehringer Ingelheim, we are rooted in our family values and take a long-term perspective. As animal enthusiasts, we come to work every day to help improve the lives of animals – be they at home, on the farm or sometimes in the wildlife.
We are committed to continuing the development of science-based innovations for the prevention of parasitic diseases that address key unmet needs, including resistance, convenience and sustainability. We have invested over 40 years into researching, developing and manufacturing one of the most trusted ranges of antiparasitic products in the world ensuring that your livestock continue to thrive.
Key Facts + Figures
Present in Over 150 Countries Worldwide
Global Headquarters in Ingelheim Germany
A Global Leader in Parasiticides
An extensive manufacturing network close to and serving markets needs
Strong R&D Centers connected to key growth areas of Europe, North America & Asia
1885
A family-owned company with 28 employees, headquartered in Ingelheim, Germany was founded by Albert Boehringer.
1897
Merieux founded the Institut Biologique Mérieux (Mérieux Biological Institute), in Lyon, France. This early vaccine research and production centre was the starting point for the animal health endeavors that would one day become the company Merial.
1955
Boehringer Ingelheim’s Animal Health division was established as the company takes over Pfizer’s veterinary program.
1997
Merial was created through the merger of Rhône Mérieux (Rhône-Poulenc, France) and MSD AgVet (Merck & Co, US).
2009
Merial becomes a wholly-owned subsidiary of Sanofi.
2015
Boehringer Ingelheim enters into exclusive negotiations with Sanofi consisting of a strategic exchange of their consumer healthcare business for Merial.
2017
Two complementary companies, Boehringer Ingelheim and Merial, unite through a passion for animals and a joint history of integrity, quality and trust.